33，Sohn YT. The effects of pseudopolymorphism on the relative bioavailability of amoxicillin[J]. Yakhak Hoechi, 1995, 39(4): 438
44，Caira MR, Pienaar EW, Loetter AP. Polymorphism and pseudopolymorphism of the antibacterial nitrofurantoin[J]. Mol Cryst Liq Cryst Sci Technol, Sect A, 1996, 279: 241
55，Roston DA, Walters MC, Rhinebarger RR, et al. Characterization of polymorphs of a new anti-inflammatory drug[J]. J Pharm Biomed Anal, 1993, 11(4-5): 293
66，Imberty A, Buleon A, Vinh T，et al. Recent advances in knowledge of starch structure[J]. Starch/Staerke. 1991, 43(10): 375
77，Dunitz JD. Phase transitions in molecular crystals from a chemical viewpoint[J]. Pure Appl Chem, 1991, 63(2): 177
88，Ip DP, Brenner GS, Stevenson JM, et al. High resolution spectroscopic evidence and solution calorimetry studies on the polymorphs of enalapril maleate[J]. Int J Pharm, 1986, 28(2-3): 183
99，Gehenot A, Rao RC, Maire G, et al. Value of thermal analysis in the critical evaluation of classical methods of melting point determination[J]. Int J Pharm, 1988, 45(1-2): 13
1010，Toscani S, Thoren S, Agafonov V, et al. Thermodynamic study of sulfanilamide Polymorphism: (Ⅰ)monotropy of the α-variety[J]. Pharm Res, 1995, 12(10): 1453
3Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1931
